April 29 (Reuters) - Valeant Pharmaceuticals (NYSE:VRX) International
Inc VRX.TO
* Files Annual Report On Form 10 K for year ended December
31, 2015
* Company in full compliance with credit agreement and
senior note indentures
* No additional items require restatement beyond those
previously disclosed
Source text for Eikon: ID:nPnb4ctgFa
Further company coverage: VRX.TO